DRUG vs MLAB

Comparison between Bright Minds Biosciences Inc (DRUG, Company) and Mesa Laboratories Inc (MLAB, Company).

DRUG is from the Healthcare sector, while MLAB is from the Technology sector.

5-Year PerformanceDRUG has outperformed MLAB, delivering a return of +22.2% compared to -16.3%

DRUG vs MLAB - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	DRUG(COMPANY)	MLAB(COMPANY)
Market Cap	$590M	$592M
Max Drawdown	97.68%	82.72%
Sharpe Ratio	1.37	0.32
5Y Beta	-0.81	1.50
Industry	Biotechnology	Scientific & Technical Instruments
P/E Ratio	-25.02	87.91
Forward P/E	N/A	35.21
PEG Ratio	-0.07	0.00
Dividend Yield	N/A	0.59%
5Y Dividends CAGR	N/A	4.56%
5Y EPS CAGR	8.42%	N/A
Debt to Equity	0.03%	36.24%
Free Cash Flow Yield	-2.46%	6.68%
P/S Ratio	N/A	2.42
P/B Ratio	2.73	3.23

Market Cap

DRUG

$590M

Winner

MLAB

$592M

Max Drawdown

DRUG

97.68%

Winner

MLAB

82.72%

Sharpe Ratio

Winner

DRUG

1.37

MLAB

0.32

5Y Beta

Winner

DRUG

-0.81

MLAB

1.50

Industry

DRUG

Biotechnology

MLAB

Scientific & Technical Instruments

P/E Ratio

Winner

DRUG

-25.02

MLAB

87.91

Forward P/E

DRUG

N/A

MLAB

35.21

PEG Ratio

Winner

DRUG

-0.07

MLAB

0.00

Dividend Yield

DRUG

N/A

MLAB

0.59%

5Y Dividends CAGR

DRUG

N/A

MLAB

4.56%

5Y EPS CAGR

DRUG

8.42%

MLAB

N/A

Debt to Equity

Winner

DRUG

0.03%

MLAB

36.24%

Free Cash Flow Yield

DRUG

-2.46%

Winner

MLAB

6.68%

P/S Ratio

DRUG

N/A

MLAB

2.42

P/B Ratio

Winner

DRUG

2.73

MLAB

3.23

DRUG vs MLAB - Historical Returns

Returns include dividend reinvestment.

Period	DRUG	MLAB
1 month	-28.00%	+1.89%
3 months	-15.64%	+35.77%
6 months	-27.60%	+36.07%
1 year	+114.76%	+6.40%
5 years(CAGR)	+22.21%	-16.35%
10 years(CAGR)	N/A	-0.99%
Max(CAGR)	+16.87%	+14.31%

DRUG

-28.00%

Winner

MLAB

+1.89%

DRUG

-15.64%

Winner

MLAB

+35.77%

DRUG

-27.60%

Winner

MLAB

+36.07%

Winner

DRUG

+114.76%

MLAB

+6.40%

5Y(CAGR)

Winner

DRUG

+22.21%

MLAB

-16.35%

10Y(CAGR)

DRUG

N/A

MLAB

-0.99%

Max(CAGR)

Winner

DRUG

+16.87%

MLAB

+14.31%

DRUG vs MLAB - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	DRUG	MLAB
2026	-26.97%	+33.22%
2025	+89.83%	-40.09%
2024	+1859.10%	+24.81%
2023	-63.33%	-38.85%
2022	-78.04%	-49.32%
2021	-41.30%	+17.79%
2020	N/A	+15.41%
2019	N/A	+20.50%
2018	N/A	+67.64%
2017	N/A	+0.93%
2016	N/A	+23.37%
2015	N/A	+25.15%
2014	N/A	+1.41%
2013	N/A	+50.43%
2012	N/A	+22.84%
2011	N/A	+39.54%
2010	N/A	+15.72%
2009	N/A	+45.62%
2008	N/A	-31.35%
2007	N/A	+34.17%
2006	N/A	+29.17%
2005	N/A	+19.22%
2004	N/A	+31.61%
2003	N/A	+56.36%
2002	N/A	+7.12%
2001	N/A	-3.84%
2000	N/A	+57.48%
1999	N/A	-4.67%

DRUG vs MLAB Drawdown Comparison

The maximum drawdown for DRUG was -97.68%, occurring on Jul 11, 2024. Recovery took 740 trading sessions.

The maximum drawdown for MLAB was -82.43%, occurring on Aug 5, 2025. This drawdown has not yet recovered.

The current DRUG drawdown is -36.50%. The current MLAB drawdown is -67.49%.

Rank	DRUG	MLAB
#1	-97.68% Nov 8, 2021 - Oct 18, 2024	-82.43% Dec 27, 2021 - Aug 5, 2025
#2	-58.28% Nov 6, 2024 - Sep 29, 2025	-43.68% Jan 9, 2008 - Dec 29, 2009
#3	-36.50% Jan 7, 2026 - Jun 12, 2026	-41.25% Mar 21, 2014 - Jul 20, 2015
#4	-27.84% Mar 22, 2021 - Aug 24, 2021	-36.60% Nov 2, 2000 - Jan 23, 2002
#5	-26.13% Oct 21, 2025 - Nov 28, 2025	-34.53% Aug 3, 2015 - Jun 6, 2016
#6	-19.30% Dec 16, 2025 - Jan 7, 2026	-31.00% Jul 23, 2007 - Jan 2, 2008
#7	-16.21% Sep 30, 2025 - Oct 9, 2025	-29.55% Apr 2, 2002 - Jul 28, 2003
#8	-14.42% Oct 11, 2021 - Nov 3, 2021	-29.39% Feb 6, 2020 - Oct 7, 2020
#9	-9.05% Oct 24, 2024 - Nov 4, 2024	-28.63% May 6, 2019 - Jan 14, 2020
#10	-7.65% Oct 14, 2025 - Oct 21, 2025	-27.52% Jan 12, 2010 - Dec 27, 2010
#11	-5.42% Dec 11, 2025 - Dec 16, 2025	-25.39% Jun 5, 2017 - Apr 13, 2018
#12	-4.62% Sep 24, 2021 - Sep 29, 2021	-25.23% Mar 12, 2012 - Jul 11, 2013
#13	-4.59% Dec 8, 2025 - Dec 10, 2025	-23.23% Jul 12, 2018 - Jan 31, 2019
#14	-4.38% Aug 24, 2021 - Sep 1, 2021	-22.38% Oct 18, 2004 - Nov 8, 2005
#15	-3.81% Sep 1, 2021 - Sep 17, 2021	-21.14% Jun 9, 2016 - Nov 17, 2016